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Abstract
Background: Translating evidence into practice requires adaptation to facilitate the 
implementation	 of	 efficacious	 interventions.	 A	 novel	 highly	 challenging	 balance	
training	program	(HiBalance)	was	found	to	improve	gait,	balance,	and	physical	activ-
ity	in	persons	with	Parkinson’s	disease	(PD)	in	an	earlier	randomized	controlled	trial.	
This study aimed to describe the adaptation process and feasibility of implementing 
the HiBalance program for PD within primary healthcare settings.
Method: Feasibility was assessed in terms of study processes and scientific evalua-
tion. Nine persons with mild–moderate PD were enrolled in this pre–post feasibility 
study.	The	dose	of	the	original	program	was	adapted	by	reducing	therapist-	led	train-
ing sessions from three to two times weekly. Outcome measures were substituted 
with ones more clinically feasible. One group (n = 5) received HiBalance training 
three times weekly for 10 weeks while another (n	=	4)	trained	twice	weekly	plus	a	
once	weekly	home	exercise	program	(HEP).	Balance	performance	was	the	primary	
outcome,	while	 secondary	 outcomes	 (e.g.,	 gait	 speed,	 physical	 activity	 level,	 con-
cerns	of	falling,	and	health-	related	quality	of	life)	were	also	evaluated.
Results:	Regarding	process	feasibility,	attendance	was	high	(approximately	90%)	 in	
both	groups,	and	experiences	of	the	group	and	home	training	were	positive.	Newly	
selected outcome measures were feasible. The scientific evaluation revealed few ad-
verse	events	and	no	serious	injuries	occurred.	Concerning	outcomes	per	group,	the	
average	change	in	balance	performance	and	gait	speed	was	equal	to,	or	exceeded,	
the minimally worthwhile treatment effect commonly used in PD.
Conclusion:	The	 findings	support	 the	 feasibility,	 in	 terms	of	process	and	scientific	
evaluation,	of	the	adapted	HiBalance	program	for	implementation	within	clinical	set-
tings.	A	sufficiently	powered	study	is	required	to	ascertain	whether	the	newly	pro-
posed	program	offers	similar	short	and	long-	term	effects	as	the	original	program.
K E Y W O R D S
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1  | INTRODUC TION
The implementation of efficacious interventions into healthcare set-
tings is necessary for improving the health of larger patient groups 
(Bradley	et	al.,	 2004).	However,	 the	 rate	 at	which	promising	 inter-
ventions are embedded within healthcare remains suboptimal be-
cause	of	challenges	related	to	implementation	(Proctor	et	al.,	2011).	
The initial demands and costs to society are considerable for imple-
menting	new	evidence	(Krisberg,	2010)	therefore,	investigating	fea-
sibility	aspects	(e.g.,	process	and	scientific	evaluation)	 is	 important	
for ensuring optimal uptake of interventions.
Parkinson’s	 disease	 (PD)	 is	 a	 neurodegenerative	 disorder	 typ-
ically resulting in deterioration of gait and balance abilities which 
predispose	 individuals	 to	more	 frequent	 falls	 and	 injuries	 (Bloem,	
Grimbergen,	Cramer,	Willemsen,	&	Zwinderman,	2001).	To	combat-	
associated	 symptoms,	 the	 HiBalance	 training	 program	 has	 been	
designed,	 including	 highly	 challenging	 and	 progressive	 exercises	
targeting dysfunctions of subsystems of balance control among 
persons	 with	 mild-	to-	moderate	 PD	 (Conradsson,	 Lofgren,	 Stahle,	
Hagstromer,	&	Franzen,	2012).	To	date,	 the	 intervention	has	been	
found	to	be	feasible	(Conradsson,	Lofgren,	Stahle,	&	Franzen,	2014)	
and	effective	at	improving	balance	and	gait	performance,	activities	
of	 daily	 living,	 and	 physical	 activity	 levels	 in	more	 controlled	 set-
tings,	that	is,	randomized	controlled	trials	(Conradsson	et	al.,	2015).	
In	order	 to	 reach	 a	 larger	proportion	of	 people	with	PD,	 the	next	
step involves testing the clinical applicability and implementation of 
the program.
Translating research protocols into clinical practice is not a 
straightforward task because a complex set of decisions and com-
promises needs to be made in order to be considered by healthcare 
planners	 and	 implementers.	However,	 protocol	 changes	 are	 rarely	
examined	in	the	literature,	especially	related	to	rehabilitation	inter-
ventions which are inherently complex. The objective of this study 
was	 to	describe	 the	adaptation	process,	 specifically	 the	necessary	
changes needed to translate a research protocol into clinical prac-
tice,	 as	well	 as	 procedural	 and	 scientific	 feasibility	of	 the	 adapted	
HiBalance program for implementation within primary healthcare 
settings.
2  | MATERIAL S AND METHODS
2.1 | Design
This feasibility study had been approved by the regional board of 
ethics	in	Stockholm.	A	typology	for	feasibility	studies,	according	to	
Thabane	et	al.,	(2010)	was	used	to	gather	insight	into	aspects	related	
to translating an intervention from more controlled to clinical set-
tings. This typology provides useful information prior to conducting 
large-	scale	 studies	 by	 providing	 insight	 into	 the	 following	 assess-
ments:	(1)	processes,	(2)	resources,	(3)	management,	and	(4)	scientific	
(effectiveness).	 For	 the	 purpose	 of	 this	 study,	 the	 specific	process 
and scientific	aspects	of	 feasibility,	as	summarized	 in	Table	1,	were	
investigated.
2.2 | Participants
Participants were consecutively recruited from a convenience sam-
ple of referrals at one primary care rehabilitation clinic in central 
Stockholm.	Fourteen	participants	were	invited	for	initial	screening,	
where nine met the following inclusion criteria: (1) a diagnosed of 
idiopathic	 Parkinson’s	 disease;	 (2)	mild–moderate	 disease	 severity	
according	to	a	Hoehn	&	Yahr,	(1967)	score	of	2	or	3;	(3)	absence	of	
noteworthy	 cognitive	 impairment;	 (4)	 age	 ≥60	years;	 (5)	 ability	 to	
independently ambulate indoors without the use of a mobility aid; 
and	 (6)	 being	 on	 a	 stable	 dose	 of	 anti-	Parkinson’s	 medication	 for	
≥3	weeks.	Five	participants	did	not	meet	 the	preliminary	 inclusion	
criteria: one due to nonidiopathic PD; two had severe impairments 
(cognitive and balance); and two with comorbidities (extreme back 
and hip pain) which could have impacted study outcomes. Written 
informed consent was obtained before first assessments were car-
ried	out.	As	per	Table	2,	the	average	age	was	71	years	and	subjects	
were	 predominantly	 female	 (6/9).	 The	 average	 time	 since	 diagno-
sis	was	 11	years,	 and	 one-	third	 experienced	 a	 fall	 during	 the	 past	
12 months.
TABLE  1 Primary purposes of feasibility studies and those 
targeted in the current study
Main reason for conducting 
pilot/feasibility studies Aspects commonly assessed
Processa
This assesses the feasibility of 
the processes that are key to 
the success of the main study
• Recruitment and retention 
rates
• (Non)compliance or 
attendance rates
•	 Eligibility	criteria	~	sufficient	
or restrictive
•	 Appropriateness	and	
understanding of data 
collection tools/outcome 
measures
•	 Length	of	time	to	complete	
all study forms
Resources 
This deals with assessing time 
and resource problems that 
can occur during the main 
study
• Determining center 
willingness and capacity
• Determining process time
• Is the equipment readily 
available when and where 
needed?
Management 
This covers potential human 
and data management 
problems
• What are the challenges that 
participating centers have 
with managing the study?
• What challenges do study 
personnel have?
Scientifica
This deals with the assessment 
of	treatment	safety,	dose,	
response,	effect,	and	variance	
of the effect
• Is the intervention safe?
• What is an effective dose 
level?
• Do patients respond to the 
intervention?
• What is the estimate of the 
treatment effect?
Note. aIndicates feasibility aspects investigated in this study.
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Due	to	the	feasibility	design,	with	our	sole	interest	in	assess-
ing the translation of the HiBalance training program from theory 
(RCT	 environment)	 to	 practice	 (clinical	 settings),	 no	 sample	 size	
calculation was needed and performed. Results from the process 
and scientific feasibility will be used to inform the larger imple-
mentation trial.
2.3 | Adaptation of the HiBalance program
The theoretical underpinnings of the HiBalance program have previ-
ously	been	described	in	detail	(Conradsson	et	al.,	2012,	2014;	Leavy,	
Kwak,	Hagströmer,	&	Franzén,	2017).	This	program	targets	subsys-
tems of balance control typically affected in PD: (1) sensory inte-
gration,	(2)	anticipatory	postural	adjustments,	(3)	motor	agility,	and	 
(4)	 stability	 limits.	 To	 target	 these	 progressive	 symptoms,	 motor	
learning	 principles,	 that	 is,	 specificity,	 progressive	 overload,	 and	
variation,	were	used	as	foundation	to	challenge	individual	progres-
sion.	The	program	is	group-	based	(4–7	persons)	and	is	facilitated	by	
two	 physical	 therapists	 (PT’s)	 who	 were	 trained	 to	 develop	 exer-
cises according to the balance control framework used in this study. 
Additionally,	the	program	incorporates	gradual	 integration	of	dual-	
tasking	 (DT)—cognitive	 (e.g.,	 counting	 or	 remembering	 items)	 and	
motor	task	(e.g.,	carrying	or	manipulating	an	object)—to	target	mild-	
associated cognitive impairments.
Adaptation	of	certain	aspects	of	the	initial	balance	training	pro-
gram was necessary to facilitate its implementation within clinical 
settings.	Firstly,	 the	 three	times	weekly	 training	dose	during	 the	
efficacy trial was reduced to align with policy regarding rehabili-
tation reimbursement in the Swedish healthcare system. Training 
dosage was discussed during a workshop by an expert group con-
sisting	 of	 PT’s	 from	hospitals	 and	 primary	 care	 facilities,	 includ-
ing	 some	with	 previous	 experience	 of	 the	 intervention,	 and	 the	
researcher	 group.	The	 final	 decision	was	 to	 reduce	 therapist-	led	
sessions to twice weekly for 10 weeks. This decision was also in-
formed by data from a previous qualitative study where partici-
pants perceived that 30 training sessions were too great a time 
commitment	 (Leavy,	 Roaldsen,	 Nylund,	 Hagstromer,	 &	 Franzen,	
2016).
To	compensate	for	this	marked	reduction,	a	home	exercise	pro-
gram	 (HEP)	was	 proposed	 and	 developed	 over	 several	months	 by	
the same expert group during a workshop and thereafter circulated 
for	comments,	where	progression	and	variation	aspects	of	exercises	
were added. Patients attending rehabilitation clinics in Sweden are 
always given home exercise programs on top of their rehabilitation 
interventions	 to	 aid	 self-	management	 and	promote	overall	 cardio-
vascular fitness. This adjunct program mainly focuses on aerobic 
capacity,	strengthening	of	lower	extremity	and	core	muscles—com-
ponents that can be performed unsupervised with minimal risk of 
falls,	 and	which	have	been	 shown	 to	 improve	balance	 control	 and	
gait	in	PD	(Roeder,	Costello,	Smith,	Stewart,	&	Kerr,	2015;	Kahle	&	
Tevald,	2014).	The	 final	program	 included	20	 therapist-	led	and	10	
individual	home	exercise	sessions.	Although	the	core	components	of	
the	program	were	left	unchanged,	it	was	necessary	to	determine	the	
feasibility of the newly proposed training schedule by investigating 
whether the intended effects were still achievable.
The other aspect for adaptation regarded the selection of out-
come measurement. Clinically applicable outcome measures were 
required	to	replace	laboratory-	based	measures	used	during	the	ef-
ficacy	trial.	Additionally,	time	efficient	measurements	were	needed	
to	ensure	clinical	feasibility.	Consequently,	the	test	battery	was	con-
densed	 to	 fewer	 performance-	based	 and	 self-	reported	 measures	
(Leavy	et	al.,	 2017).	 The	primary	outcome,	 that	 is,	 balance	perfor-
mance	measured	with	the	Mini-	BESTest,	remained	unchanged.
2.4 | Feasibility of the adapted HiBalance program
2.4.1 | Process assessment
For	 the	 assessment	 of	 process	 feasibility,	 attendance/adherence	
rates,	 eligibility	 criteria,	 the	 appropriateness	 of	 data	 collection	
tools/outcome	measures,	time	taken	to	complete	all	measurements,	
and	 participants’	 experiences	 of	 the	 program	 were	 investigated.	
Attendance rate was measured by recording individual participation 
over	the	10-	week	period	and	reasons	for	missed	sessions.	The	eli-
gibility criteria	reflected	the	efficacy	trial:	persons	≥60	years	of	age	
with mild–moderate PD. Clinically applicable outcome measures 
were	 selected	by	experts	 at	 the	workshop	 to	 replace	 laboratory-	
based	 tests.	 The	 Mini-	BESTest,	 (14-	item	 performance-	based	
measure	 of	 dynamic	 balance),	 was	 used	 as	 in	 the	 efficacy	 trial.	
Conversely,	gait	speed	was	manually	assessed	with	the	timed	10-	m	
walk	 test,	 as	opposed	 to	 the	electronic	walkway.	The	6-	min	walk	
test	was	added	to	evaluate	exercise	endurance.	Lastly,	accelerom-
etery	 (Actigraph	 GT3X	 +,	 Pensacola,	 USA)	 measured	 free-	living	
physical	 activity	 by	 aggregating	 step	 counts.	 Self-	reported	meas-
ures	included	the	Falls	Efficacy	Scale–International	(FES-	I)	for	eval-
uating	concerns	of	falling,	the	Walk-	12	(Swedish	version	Walk-	12G)	
TABLE  2 Participants’	baseline	characteristics
Subjects Gender
Age 
(years)
H&Y 
stage
Mini- 
BESTest
Gait 
speed 
(m/s)
Group	3x
P1 F 68 2 24 1.26
P2 M 75 2 23 1.29
P3 F 83 3 16 0.79
P4 F 70 3 19 1.03
P5 F 61 2 27 1.36
Group	2x	+	HEP
P1 M 69 3 21 1.14
P2 F 76 2 21 1.14
P3 M 70 2 24 1.12
P4 F 66 2 23 0.91
Note.	Group	3x:	received	supervised	balance	training	three	times	weekly	
for	 10	weeks.	 Group	 2x	 +HEP:	 received	 supervised	 balance	 training	
twice	weekly	for	10	weeks	plus	a	once	weekly	HEP.
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evaluated	self-	perceived	limitations	in	walking	ability,	and	the	EQ-	
5D	assessed	health-	related	quality	of	life.	Time	taken	to	complete	
testing	was	recorded	for	all	individuals.	Upon	program	completion,	
participants reported their perception of the balance training and 
HEP	using	a	questionnaire.
2.4.2 | Scientific assessment
Safety of the intervention was assessed by recording the nature and 
frequency	of	adverse	events	which	 included	falls,	 injuries,	 fatigue,	
and pain. To assess the effectiveness (responsiveness) of the newly 
proposed	dose,	 participants	were	 randomized	 to	 (1)	 receive	 train-
ing	three	times	weekly	(Group	3x),	 (2)	receive	group	training	twice	
weekly	and	perform	the	HEP	once	a	week	(Group	2x	+	HEP).
2.5 | Data analysis
Data	were	analyzed	descriptively,	using	the	proportion	of	individuals	
per	group	who	changed	 their	outcome	status	at	post-	testing.	This	
study	was	 not	 sufficiently	 powered	 to	 test	 between-	group	 differ-
ences and report on the statistical superiority of one training dose 
over	the	other.	However,	we	discussed	the	observed	changes	in	rela-
tion to their clinically meaningful important differences.
3  | RESULTS
3.1 | Process assessment: attendance, data 
collection procedure, and experiences
Group	3x	attended	137	of	150	sessions	 (91%)	and	Group	2x	+	HEP,	
74	of	80	therapist-	led	sessions	(93%)	and	32	of	40	(80%)	home	train-
ing	sessions.	All	data	collection	procedures,	that	is,	self-	reported	out-
comes	 and	 clinical	 tests,	were	 completed	with	 ease	by	participants,	
indicating	the	clinical	feasibility	of	selected	measures.	Measurements	
took	between	90	and	120	min	to	complete.	Concerning	recruitment,	
a	number	of	patients	under	60	years,	but	who	fulfill	all	other	criteria,	
was	 excluded,	which	 suggested	broadening	of	 the	 inclusion	 criteria.	
Both	 groups	 reported	 therapist-	led	 sessions	 as	 balance	 challenging	
and	 exercise	 difficulty	 as	 progressive	 in	 nature,	 especially	 with	 the	
introduction	 of	 dual-	tasking.	 All	 participants,	 including	 the	 subject	
who	had	missed	some	official	HEP	sessions,	 in	the	Group	2x	+	HEP,	
expressed	their	willingness	to	continue	with	the	HEP	after	the	inter-
vention period.
3.2 | Scientific assessment: safety and effectiveness
Concerning	adverse	events	during	therapist-	led	sessions,	three	partici-
pants fell without causing injury; all stumbled over artificial hindrances 
that	were	created	to	challenge	balance.	Another	participant	reported	
pain	associated	with	the	training	which	lasted	more	than	2	days,	and	
another	felt	dizzy	during	the	session	but	recovered	after	a	resting	pe-
riod.	No	participant	reported	negative	events	during	the	HEP.
Four	of	five	individuals	in	Group	3x	improved	their	balance	per-
formance	and	two	of	four	in	Group	2x	+	HEP,	while	no	one	reduced	
their balance function (Figure 1). The average improvement in bal-
ance performance following the training period was two points and 
one	point	in	Group	3x	and	Group	2x	+	HEP,	respectively.	Four	of	five	
(80%)	in	Group	3x,	and	all	(100%)	in	Group	2x	+	HEP,	improved	their	
gait	speed	following	training.	Those	in	Group	3x	improved	their	gait	
speed	by	0.05	m/s	on	average,	whereas	 those	 in	Group	2x	+	HEP	
improved	 it	by	0.17	m/s.	Furthermore,	both	groups	 improved	their	
walking	endurance	(6MWT)	and	four	of	five	individuals	in	Group	3x,	
and	three	of	 four	 in	Group	2x	+	HEP,	 indicated	fewer	concerns	of	
falling following training. No noteworthy differences in pre–post 
measures	 were	 found	 for	 physical	 activity	 level,	 self-	perceived	
walking	ability,	 and	health-	related	quality	of	 life	 (EQ-	5D)	after	 the	
intervention.
4  | DISCUSSION
Results of this study reveal that the adapted HiBalance pro-
gram was feasible in mild–moderate PD within a primary health-
care	setting,	 in	 that	attendance	 rates	were	high,	adverse	events	
few,	 and	 the	 effects	 on	 balance	 performance	 and	 secondary	
outcomes were detectable and favorable. The results support 
F IGURE  1  (a)	Mini-	BESTest	scores	and	
(b)	gait	speed	pre-	and	postintervention
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initial feasibility of the intervention which was adapted to suit 
the	healthcare	context.	However,	a	larger	and	more	rigorously	de-
signed multisite study is required to establish whether the newly 
adapted	program	offers	similar	short-	and	long-	term	effects	as	the	
original program.
According	to	the	feasibility	typology,	assessment	of	the	process	
revealed	good	adherence	as	approximately	90%	of	the	total	sessions	
were attended by participants. The eligibility criteria were similar to 
that	used	in	the	RCT	(Conradsson	et	al.,	2015)	however,	the	recruit-
ment process revealed that younger patients (<60 years) are com-
monly referred to rehabilitation in primary healthcare settings. To 
promote	access,	the	implementation	trial	will	include	persons	of	all	
ages. Participants completed the newly selected outcome measures 
with	 ease.	 This	 could	be	because	 some	of	 the	 selected	measures,	
such	as	the	EQ-	5D	and	6MWT,	are	part	of	existing	routine	practice.	
However,	PT’s	reported	that	almost	2	hr	of	data	collection	per	par-
ticipant	was	not	clinically	 feasible,	and	 the	6MWT	was	 resultantly	
removed	from	the	test	battery,	while	the	Walk-	12,	FES-	I,	and	EQ-	5D	
were	suggested	to	be	completed	by	participants	at	home.	Overall,	
participants’	experiences	were	positive	and	all	felt	challenged	by	the	
program.
As	 part	 of	 the	 scientific	 evaluation,	 adverse	 events	 were	 few	
during	the	therapist-	led	training	program	and	HEP.	Three	falls	were	
recorded	 during	 the	 training	 sessions,	 with	 all	 of	 them	 occurring	
during	the	advance	stages	of	exercise	progression.	All	falls	occurred	
on	a	soft	surface	and	no	injuries	were	reported.	Risk	of	falls,	how-
ever,	cannot	be	removed	during	training	sessions	due	to	the	highly	
challenging	nature	of	the	program.	To	minimize	falls,	challenging	bal-
ance	exercises	were	not	 included	 in	 the	HEP,	while	PT’s	 remained	
near participants during training sessions.
Training resulted in improved balance performance. Despite the 
small	sample	size,	both	groups	improved	their	balance	performance	by	
at	least	one	point	on	the	Mini-	BESTest,	which	is	also	the	minimal	de-
tectable	change	in	mild–moderate	PD	(Löfgren,	Lenholm,	Conradsson,	
Ståhle,	&	Franzén,	2014).	Similar	positive	trends	were	found	for	second-
ary	outcomes,	that	is,	gait	speed,	concerns	of	falling,	and	exercise	en-
durance.	In	fact,	a	similar	(average)	difference	in	gait	speed	was	found	
following	training	in	the	Group	2x	+	HEP	when	compared	to	the	effi-
cacy	trial	(Conradsson	et	al.,	2015).	The	fact	that	the	findings	of	the	two	
studies corroborate are an indication of the potential effectiveness of 
the adapted training dose in the current study.
This	study	presented	with	several	limitations.	Firstly,	the	sample	
size	was	too	small	to	sufficiently	power	outcomes	and	to	adequately	
evaluate	 adverse	 events.	 Also,	 the	 lack	 of	 a	 control	 group	 under-
mined	 true	 treatment	effects.	 Lastly,	 the	 lack	of	 assessor	blinding	
may	 have	 introduced	 measurement	 bias.	 Taken	 together,	 future	
larger and more rigorously designed studies are warranted to pro-
vide	evidence	on	 the	cost-	effectiveness	of	 the	adapted	HiBalance	
training program within clinical settings. Translating this training 
program into practice may offer clinicians an effective option to 
retrain	and	maintain	balance	and	gait	 in	persons	with	PD,	an	area	
that	 lacked	proven	 interventions	 (Conradsson,	 Leavy,	Hagströmer,	
Nilsson,	&	Franzén,	2017;	Tomlinson	et	al.,	2012).
In	 conclusion,	 this	 study	 demonstrates	 that	 the	 adapted	
HiBalance program is feasible from both a process and scientific/
effectiveness	perspective.	A	larger	multisite	study	is	needed	to	test	
the effectiveness of the adapted program on balance and gait out-
comes as well as to inform future widespread implementation.
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